Global Healthcare CRO Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Contract research organizations (CROs) have transformed the way research are conducted by several pharmaceutical, biotechnology, and medical devices companies in ways more than one. These organizations offer a variety of services such as biopharmaceutical development, clinical trials conduct and other endeavors, drug discovery activities, product commercialization, assay development, and pharmacovigilance. The intensifying demand for new therapies and devices has mounted pressures on research and development (R&D) budgets of these organizations. 

Scope of the Report:
The global Healthcare CRO market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Healthcare CRO.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Healthcare CRO market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Healthcare CRO market by product type and applications/end industries.

Market Segment by Companies, this report covers
Quintiles Transnational Holdings
Laboratory Corporation Of America Holdings
Pharmaceutical Product Development
PAREXEL International
ICON plc
PRA Health Sciences
InVentiv Health
Charles River Laboratories
INC Research Holdings
Wuxi PharmaTech

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Early Phase Development
Clinical Research
Laboratory
Consulting Services

Market Segment by Applications, can be divided into
Biopharmaceutical Companies
Academic and Research Institutes
Others